By integrating this result with the one in 2.3.4 mentioned above, it was revealed that the targets in the lipid and atherosclerosis, including IL6, CXCL8, CASP3, MAPK1, PRKCA, PPARγ, MAPK14, TNF, TP53, ICAM1, MAPK3, could be the clinical therapeutic targets. This evidence concerns the gene PPARG and atherosclerosis.